New York, NY -- (SBWIRE) -- 10/17/2013 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today We bring special trend analysis of following stocks: Celldex Therapeutics, Inc. (NASDAQ:CLDX), Pandora Media Inc (NYSE:P), Pharmacyclics, Inc. (NASDAQ:PCYC), Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
Celldex Therapeutics, Inc. (NASDAQ:CLDX) ended higher +6.07% and complete the day at $27.78. The total number of shares changed hands during the day was 2.21 million. After opening at $26.52, the stock hit as high as $27.91. However, it traded between $5.02 and $38.84 over the last twelve months. Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States.
For How Long CLDX will Fight for Profitability? Read This Trend Analysis report
Pandora Media Inc (NYSE:P) closed yesterday at $26.70, a +6.04% increase. Around 256.52 million shares were traded, beating an-average trading volume of 12.72 million shares. The company is now valued at around $5.12 billion. Pandora Media, Inc. provides Internet radio services in the United States. The company allows listeners to create up to 100 personalized stations to access unlimited hours of free music and comedy, as well as offers Pandora One, a paid subscription service to listeners.
For How Long P’s Gloss will Attract Investors? Find out via this report
Pharmacyclics, Inc. (NASDAQ:PCYC) moved +5.95 percent higher at $131.49 and traded between $125.49 and $131.87 after opening the day at $125.49. Its performance over the last five days remained -5.8%, which stands at +10.54% for a month. Going back further than one month, 1-year performance after recent close was +127.57%. Pharmacyclics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of small-molecule drugs for the treatment of cancer and immune mediated diseases.
For How Long PCYC’s Gloss will Attract Investors? Find out via this report
Regeneron Pharmaceuticals Inc (NASDAQ:REGN)’s shares rose, +5.93 percent to close at $307.65. The stock is up around +79.84% this year and +104.11% for the last 12 months. Around 1.18 million shares changed hands yesterday, higher from an-average trading volume of 759,833 shares. Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally.
Why Should Investors Buy REGN After The Recent Gain? Just Go Here and Find Out
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)